Merus N.V. (MRUS) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MRUS Revenue Growth
Revenue Breakdown (FY 2024)
MRUS's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
MRUS Revenue Analysis (2013–2024)
As of May 8, 2026, Merus N.V. (MRUS) generated trailing twelve-month (TTM) revenue of $51.2 million, reflecting slight decline in growth of -1.9% year-over-year. The most recent quarter (Q3 2025) recorded $10.4 million in revenue, up 38.4% sequentially.
Looking at the longer-term picture, MRUS's 5-year compound annual growth rate (CAGR) stands at +4.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $43.1 million in 2021.
Revenue diversification analysis shows MRUS's business is primarily driven by Collaboration Revenue (100%). With over half of revenue concentrated in Collaboration Revenue, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ZYME (-15.6% YoY), AGEN (+10.4% YoY), and FATE (-51.2% YoY), MRUS has underperformed the peer group in terms of revenue growth. Compare MRUS vs ZYME →
MRUS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MRUSCurrent | $51M | -1.9% | +4.7% | -753.0% | |
 ZYME | $106M | -15.6% | +22.2% | -87.3% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% | |
 XNCR | $126M | -32.5% | +0.5% | -141.4% |
MRUS Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $34.9M | -12.4% | $13.0M | 37.2% | $-262,626,275 | -753.0% |
| 2023 | $39.8M | +2.5% | $29.3M | 73.6% | $-141,800,272 | -356.2% |
| 2022 | $38.8M | -10.0% | $28.9M | 74.4% | $-149,459,488 | -384.8% |
| 2021 | $43.1M | +76.0% | $-43,121,688 | -99.9% | $-79,052,913 | -183.2% |
| 2020 | $24.5M | -11.7% | $-32,823,404 | -133.9% | $-62,113,730 | -253.4% |
| 2019 | $27.8M | -17.1% | $-21,883,650 | -78.8% | $-52,292,715 | -188.4% |
| 2018 | $33.5M | +52.9% | $-14,305,958 | -42.7% | $-39,929,064 | -119.2% |
| 2017 | $21.9M | +773.1% | $-12,210,000 | -55.7% | $-35,302,000 | -161.1% |
| 2016 | $2.5M | +31.8% | $-15,914,000 | -634.0% | $-27,881,000 | -1110.8% |
| 2015 | $1.9M | +46.2% | $-14,276,000 | -749.4% | $-23,111,000 | -1213.2% |
See MRUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MRUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MRUS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMRUS — Frequently Asked Questions
Quick answers to the most common questions about buying MRUS stock.
Is MRUS's revenue growth accelerating or slowing?
MRUS revenue growth slowed to -1.9%, below the 5-year CAGR of +4.7%. TTM revenue is $51M. The deceleration marks a shift from historical growth rates.
What is MRUS's long-term revenue growth rate?
Merus N.V.'s 5-year revenue CAGR of +4.7% reflects the variable expansion pattern. Current YoY growth of -1.9% is near this long-term average.
How is MRUS's revenue distributed by segment?
MRUS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.